The provided data indicates a decreasing trend in the use of antibacterial medicine in the UK, with a Compound Annual Growth Rate (CAGR) of -1.21% leading up to 2023 and a forecasted CAGR of -2.07% from 2023 to 2028. This suggests a consistent decline in usage over the past decade, accentuated by a significant drop in 2020, likely due to the COVID-19 pandemic. The forecasted 5-year growth rate of -9.94% implies a continued decrease in antibacterial medicine consumption.
Future trends to watch include the impact of antimicrobial resistance initiatives, changes in prescribing behaviors, and the development of new antibacterial treatments that could alter consumption patterns.
